Network meta-analysis of nine large cardiovascular outcome trials of new antidiabetic drugs

• GLP-1 receptor agonists showed CV benefit compared to placebo. • SGLT-2 inhibitors resulted in a significant reduction in heart failure hospitalizations. • DPP-4 inhibitors are comparable to placebo in terms of CV safety. • The NMA showed no significant differences among the medications of each cl...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
1. Verfasser:	Alfayez, Osamah M. (VerfasserIn)
Weitere Verfasser:	Al Yami, Majed S. (BerichterstatterIn), Alshibani, Mohannad (BerichterstatterIn), Fallatah, Saad B. (BerichterstatterIn), Al Khushaym, Nasser M. (BerichterstatterIn), Alsheikh, Razan (BerichterstatterIn), Alkhatib, Nimer (BerichterstatterIn)
Format:	Online-Aufsatz
Sprache:	English
Veröffentlicht:	2019
Zugriff auf das übergeordnete Werk:	A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
Schlagworte:	T2DM CV NMA MACE GLP-1 agonist DPP-4 inhibitor SGLT-2 inhibitor CVOT MI HF
Umfang:	8